International clinical trial to test the use of dye during children’s cancer surgery
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
A clinical trial testing the use of the 'pink drink' dye in children with brain tumours.
Testing whether a combination of drugs could reduce the risk of relapse and limit side effects.
Packing medicines into heat-sensitive liposomes to transport cancer treatments into the brain.
Investigating how antibody immunotherapy causes pain and nerve damage.
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
Finding drugs which target genes that drive high-risk acute lymphoblastic leukaemia.
Testing nanoparticles as a way of getting drugs where they are needed for acute myeloid leukaemia.
Stopping protein activity to stop anaplastic large cell lymphomas from growing.